New Delhi [India], June 29 (ANI): The company is ready to roll out India's first mRNA vaccine in 72 hours after the government's permission, said Gennova Biopharmaceuticals Ltd Chief Executive Officer and Whole-time Director Dr Sanjay Singh.
New Delhi [India], June 28 (ANI): The National Technical Advisory Group on Immunisation (NTAGI) reviewed the data and recommended the vaccination for Typhoid and Cervical Cancer, said sources on Tuesday.
New Delhi [India], June 16 (ANI): Government advisory panel Standing Technical Sub Committee (STSC) of the National Technical Advisory Group on Immunization (NTAGI) has recommended reducing the time period between the second dose and precaution dose of the vaccine against the Coronavirus inf
Narmada (Gujarat) [India], May 6 (ANI): National Technical Advisory Group on Immunisation (NTAGI) chief Dr NK Arora on Thursday said that for the first time after 70-75 years, health has come on the political agenda.
New Delhi [India], May 5 (ANI): The COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) has recommended allowing the administration of precautionary doses before nine months for those who are travelling abroad according to the receiving country's needs,
New Delhi [India], May 2 (ANI): The COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will review the data of COVID-19 vaccines for the children aged 5 to 12 years on May 4, said sources on Monday.
New Delhi [India], April 30 (ANI): The National Technical Advisory Group on Immunisation (NTAGI) recommended that the Russian COVID-19 vaccine Sputnik Light which contains the same ingredients as the first dose of Sputnik V can be taken as a precaution dose, said Sources.
New Delhi [India], April 30 (ANI): The Government of India has not reduced the time gap for administering 'precaution dose' of COVID-19 vaccine from nine months to six months, official sources said on Saturday.
New Delhi [India], April 29 (ANI): National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
New Delhi [India], April 11 (ANI): The Indian SARS Cov2 genomic consortium (INSACOG) is looking into the results of samples collected from 15 states and 19 sewage sites for COVID-19 and plans to increase more sites for sewage sample collection, said NTAGI Chairman Dr N K Arora on Monday.
New Delhi [India], April 11 (ANI): New COVID-19 variants will keep coming, however, the new variants aren't causing severe diseases or increasing the number of cases said Chairman of the COVID-19 working group of India, National Technical Advisory Group on Immunisation (NTAGI), Dr NK Aror
New Delhi [India], March 30 (ANI): The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine -- Covovax for use for children and adults, on April 1, sources informed on Wednesday.